N-去烷基氟西泮
 | |
 | |
| 法律規範狀態 | |
|---|---|
| 法律規範 |
|
| 識別資訊 | |
| |
| CAS號 | 2886-65-9 |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.018.863 |
| 化學資訊 | |
| 化學式 | C15H10ClFN2O |
| 摩爾質量 | 288.71 g·mol−1 |
| 3D模型（JSmol） | |
| 熔點 | 205至206 °C（401至403 °F） [1] |
| |
N-去烷基氟西泮（N-Desalkylflurazepam）又稱去甲氟西泮（norflurazepam）是一種苯二氮卓類藥物的類似物，亦是包括氟西泮[2]、氟托西泮[3]、氟地西泮[4]、咪達唑侖[5]、氟他唑侖[6]、夸西泮[7]與氯氟卓乙酯在內的若干其他苯二氮卓類藥物的活性代謝產物[8][9]。其作用時間長，易於蓄積，且會與苯二氮卓受體的各種不同亞型進行非選擇性結合[7]。從 2016 年起其便作為策劃藥出售[10]。
參考
- ^ SciFinder record for CAS#2886-65-9
- ^ Riva R, de Anna M, Albani F, Baruzzi A. Rapid quantitation of flurazepam and its major metabolite, N-desalkylflurazepam, in human plasma by gas-liquid chromatography with electron-capture detection. Journal of Chromatography. March 1981, 222 (3): 491–5. PMID 7228960. doi:10.1016/S0378-4347(00)84153-5.
- ^ Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E. Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects. European Journal of Drug Metabolism and Pharmacokinetics. 1989, 14 (4): 293–8. PMID 2633923. S2CID 20710732. doi:10.1007/bf03190114.
- ^ Human Toxicology 1st. Elsevier Science. December 1996: 43.
- ^ Vogt S, Kempf J, Buttler J, Auwärter V, Weinmann W. Desalkylflurazepam found in patients' samples after high-dose midazolam treatment. Drug Testing and Analysis. 2013, 5 (9–10): 745–7. PMID 23713025. doi:10.1002/dta.1484.
- ^ Miyaguchi H, Kuwayama K, Tsujikawa K, Kanamori T, Iwata YT, Inoue H, Kishi T. A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry. Forensic Science International. February 2006, 157 (1): 57–70. PMID 15869852. doi:10.1016/j.forsciint.2005.03.011.
- ^ 7.0 7.1 Nikaido AM, Ellinwood EH. Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance. Psychopharmacology. 1987, 92 (4): 459–64. PMID 2888152. S2CID 13162524. doi:10.1007/bf00176478.
- ^ Ba BB, Iliadis A, Cano JP. Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites. Annals of Biomedical Engineering. 1989, 17 (6): 633–46. PMID 2574017. S2CID 31310535. doi:10.1007/bf02367467.
- ^ Davi H, Guyonnet J, Necciari J, Cautreels W. Determination of circulating ethyl loflazepate metabolites in the baboon by radio-high-performance liquid chromatography with injection of crude plasma samples: comparison with solvent extraction and thin-layer chromatography. Journal of Chromatography. July 1985, 342 (1): 159–65. PMID 2864352. doi:10.1016/S0378-4347(00)84498-9.
- ^ Manchester KR, Maskell PD, Waters L. a and plasma protein binding values for benzodiazepines appearing as new psychoactive substances. Drug Testing and Analysis. March 2018, 10 (8): 1258–1269. PMID 29582576. doi:10.1002/dta.2387.